Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets
Dae Ho Lee, Sang-We Kim, Cheolwon Suh, Yun Hee Han, Jung-Shin LeeVolume:
67
Language:
english
Pages:
5
DOI:
10.1007/s00280-010-1280-6
Date:
January, 2011
File:
PDF, 241 KB
english, 2011